Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(6), P. 604 - 604
Published: June 14, 2024
Objective:
To
characterize
the
cognitive
profile
of
long
COVID-19
subjects
and
its
possible
association
with
clinical
symptoms,
emotional
disturbance,
biomarkers,
disease
severity.
Methods:
We
performed
a
single-center
cross-sectional
cohort
study.
Subjects
between
20
60
years
old
confirmed
infection
were
included.
The
assessment
was
6
months
following
hospital
or
ambulatory
discharge.
Excluded
those
prior
neurocognitive
impairment
severe
neurological/neuropsychiatric
disorders.
Demographic
laboratory
data
extracted
from
medical
records.
Results:
Altogether,
108
participants
included,
64
male
(59.25%),
mean
age
49.10
years.
patients
classified
into
four
groups:
non-hospitalized
(NH,
n
=
10),
hospitalized
without
Intensive
Care
Unit
(ICU)
oxygen
therapy
(HOSPI,
21),
ICU
but
(OXY,
56),
(ICU,
21)
patients.
In
total,
38
(35.18%)
reported
Subjective
Cognitive
Complaints
(SCC).
No
differences
found
considering
illness
severity
groups.
Females
had
more
persistent
symptoms
SCC
than
males.
Persistent
dyspnea
headache
associated
higher
scores
in
anxiety
depression.
fatigue,
anxiety,
depression
worse
overall
cognition.
Conclusions:
regarding
post-COVID-19
infection.
not
performance,
frequent
independent
Fatigue,
linked
to
poorer
function.
Tests
for
attention,
processing
speed,
executive
function
most
sensitive
detecting
changes
these
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: July 11, 2023
There
has
been
an
increasing
interest
in
the
long-term
impact
of
long
COVID.
However,
only
a
few
studies
have
investigated
clinical
manifestations
COVID
after
24
months
acute
infection.
In
this
study,
prospective
online
surveys
were
conducted
adults
previously
diagnosed
with
coronavirus
disease
2019
(COVID-19)
South
Korea
between
February
13
and
March
13,
2020,
at
6,
12,
COVID-19.
We
self-reported
symptoms
EuroQol-5-dimension
index.
Among
900
individuals
enrolled
initially,
150
completed
all
3
surveys.
After
excluding
cases
COVID-19
reinfection,
132
included
final
analysis.
participants,
94
(71.2%)
experienced
The
most
frequently
reported
fatigue
(34.8%),
amnesia
(30.3%),
concentration
difficulties
(24.2%),
insomnia
(20.5%),
depression
(19.7%).
Notably,
no
significant
differences
noted
incidence
terms
number
vaccinations
received.
Although
neuropsychiatric
quality
life
improved
over
time,
it
continued
to
affect
32.7%
participants.
Symptoms
COVID,
particularly
symptoms,
tend
persist
vaccination
or
received
may
not
significantly
Journal of the Formosan Medical Association,
Journal Year:
2023,
Volume and Issue:
123, P. S61 - S69
Published: April 13, 2023
Coronavirus
disease
2019
(COVID-19)
has
caused
tremendous
morbidity
and
mortality
worldwide.
The
large
number
of
post-COVID
survivors
drawn
attention
to
the
management
condition,
known
as
long
COVID.
This
review
examines
current
knowledge
COVID,
regarding
its
epidemiology,
mechanism,
clinical
presentations
in
both
adults
children.
We
also
rehabilitation
principles,
modules,
effects,
share
Taiwan's
efforts
provide
a
top-down,
nationwide
care
framework
for
COVID
patients.
Dyspnea,
chronic
cough,
fatigue
are
most
commonly
reported
symptoms
first
6
months
after
infection,
but
cognitive
impairment
psychological
may
persist
beyond
this
time.
Several
possible
mechanisms
behind
these
were
proposed,
remained
unconfirmed.
These
negatively
impact
individuals'
function,
activities,
participation
quality
life.
Rehabilitation
is
key
element
achieve
functional
improvement.
Early
should
start
with
comprehensive
evaluation
identification
red
flags.
Exercise-based
therapy,
an
essential
part
can
be
conducted
different
including
telerehabilitation.
Post-exertional
symptom
exacerbation
orthostatic
hypotension
carefully
monitored
during
exercise.
Randomized
control
trials
sample
size
needed
determine
optimal
timing,
dosage,
modules.
JAMA Health Forum,
Journal Year:
2023,
Volume and Issue:
4(7), P. e231933 - e231933
Published: July 7, 2023
Importance
Post–COVID-19
condition
(PCC),
also
known
as
long
COVID,
encompasses
the
range
of
symptoms
and
sequelae
that
affect
many
people
with
prior
SARS-CoV-2
infection.
Understanding
functional,
health,
economic
effects
PCC
is
important
in
determining
how
health
care
systems
may
optimally
deliver
to
individuals
PCC.
Observations
A
rapid
review
literature
showed
hospitalization
for
severe
critical
illness
limit
a
person’s
ability
perform
day-to-day
activities
employment,
increase
their
risk
incident
conditions
use
primary
short-term
services,
have
negative
association
household
financial
stability.
Care
pathways
integrate
care,
rehabilitation
specialized
assessment
clinics
are
being
developed
support
needs
However,
comparative
studies
determine
optimal
models
based
on
effectiveness
costs
remain
limited.
The
likely
large-scale
associations
economies
will
require
substantial
investment
research,
clinical
policy
mitigate
these
effects.
Conclusions
Relevance
An
accurate
understanding
additional
at
individual
system
levels
informing
resource
planning,
including
identification
affected
by
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Jan. 9, 2024
Abstract
This
prospective
cohort
study
aimed
to
identify
characteristics
of
long
COVID
and
any
potential
mitigating
effects
COVID-19
vaccinations
in
patients
24
months
following
infection.
Adult
diagnosed
with
between
February
17,
2020,
March
24,
were
scheduled
visit
the
hospital
four
times
(6,
12,
18,
after
infection)
assess
their
symptoms,
quality
life,
mental
health.
Among
235
patients,
121
(51.5%)
completed
visits.
Of
these,
59.5%
female,
a
median
age
52
years.
Mild
moderate
disease
severity
identified
101
(83.4%)
patients.
A
total
75
participants
(62.0%)
still
experiencing
symptoms
acute
Fatigue,
amnesia,
difficulty
concentrating,
insomnia
most
common
symptoms.
The
frequency
neuropsychiatric
did
not
differ
based
on
vaccination
status
or
number
doses
received.
Quality
life
improved
over
time
for
participants,
but
32.2%
respondents
reported
anxiety/depression
at
end
study.
Overall,
our
demonstrates
that
can
persist
up
infection,
affecting
health
life.
Infection and Chemotherapy,
Journal Year:
2024,
Volume and Issue:
56(1), P. 122 - 122
Published: Jan. 1, 2024
"Long
COVID"
is
a
term
used
to
describe
condition
when
the
symptoms
and
signs
associated
with
coronavirus
disease
2019
(COVID-19)
persist
for
more
than
three
months
among
patients
infected
COVID-19;
this
has
been
reported
globally
poses
serious
public
health
issue.
Long
COVID
can
manifest
in
various
forms,
highlighting
need
appropriate
evaluation
management
by
experts
from
fields.
However,
due
lack
of
clear
clinical
definitions,
knowledge
pathophysiology,
diagnostic
methods,
treatment
protocols,
it
necessary
develop
best
standard
guidelines
based
on
scientific
evidence
date.
We
developed
guideline
diagnosing
treating
long
analyzing
latest
research
data
collected
start
COVID-19
pandemic
until
June
2023,
along
consensus
expert
opinions.
This
provides
recommendations
diagnosis
that
be
applied
practice,
total
32
key
questions
related
COVID.
The
should
comprehensive,
including
medical
history,
physical
examination,
blood
tests,
imaging
studies,
functional
tests.
To
reduce
risk
developing
COVID,
vaccination
antiviral
during
acute
phase
are
recommended.
will
revised
there
reasonable
updates
availability
new
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(7), P. 835 - 835
Published: July 11, 2024
Long
COVID,
a
name
often
given
to
the
persistent
symptoms
following
acute
SARS-CoV-2
infection,
poses
multifaceted
challenge
for
health.
This
review
explores
intrinsic
relationship
between
comorbidities
and
autoimmune
responses
in
shaping
trajectory
of
long
COVID.
Autoantibodies
have
emerged
as
significant
players
COVID-19
pathophysiology,
with
implications
disease
severity
progression.
Studies
show
immune
dysregulation
persisting
months
after
marked
by
activated
innate
cells
high
cytokine
levels.
The
presence
autoantibodies
against
various
autoantigens
suggests
their
potential
comorbid
factors
Additionally,
formation
complexes
may
lead
severe
progression,
highlighting
urgency
early
detection
intervention.
Furthermore,
COVID
is
highly
linked
cardiovascular
complications
neurological
symptoms,
posing
challenges
diagnosis
management.
Multidisciplinary
approaches,
including
vaccination,
tailored
rehabilitation,
pharmacological
interventions,
are
used
mitigating
COVID’s
burden.
However,
numerous
persist,
from
evolving
diagnostic
criteria
addressing
psychosocial
impact
predicting
outcomes.
Leveraging
AI-based
applications
holds
promise
enhancing
patient
management
improving
our
understanding
As
research
continues
unfold,
unravelling
complexities
remains
paramount
effective
intervention
care.
Journal of Korean Medical Science,
Journal Year:
2022,
Volume and Issue:
37(47)
Published: Jan. 1, 2022
Since
its
first
emergence
in
late
2019,
severe
acute
respiratory
syndrome
coronavirus-2
has
claimed
more
than
6.5
million
lives
worldwide
and
continues
to
infect
hundreds
of
thousands
people
daily.
To
combat
this
once-in-a-century
disaster,
several
vaccines
have
been
developed
at
unprecedented
speeds.
Novel
vaccine
platforms
(messenger
ribonucleic
acid
adenoviral
vector
vaccines)
played
a
major
role
the
current
pandemic.
In
Korea,
six
vaccines,
including
domestically
recombinant
vaccine,
approved.
As
other
countries,
proven
be
safe
highly
effective
Korea.
However,
rare
serious
adverse
events
breakthrough
infections
undermined
public
trust
even
while
benefits
vaccination
far
outweigh
risks.
The
rise
omicron
variant
subsequent
increase
excess
mortality
demonstrated
that
are
key
component
pandemic
response,
it
alone
can
fail
without
non-pharmaceutical
interventions
like
masking
social
distancing.
coronavirus
disease
revealed
both
strengths
weaknesses
our
healthcare
system
preparedness.
When
next
arrives,
improved
risk
communication
development
should
prioritized.
enable
timely
development,
is
essential
make
strategic
sufficient
investments
research
development.
Allergy Asthma and Immunology Research,
Journal Year:
2023,
Volume and Issue:
15(3), P. 395 - 395
Published: Jan. 1, 2023
Cough
is
one
of
the
most
common
symptoms
acute
coronavirus
disease
2019,
but
cough
may
persist
for
weeks
or
months.
This
study
aimed
to
examine
clinical
characteristics
patients
with
post-coronavirus
(COVID)
persistent
in
Omicron
era.
We
conducted
a
pooled
analysis
comparing
3
different
groups:
1)
prospective
cohort
post-COVID
(>
weeks;
n
=
55),
2)
retrospective
66),
and
3)
non-COVID
chronic
(CC)
8
100).
health
status
was
assessed
using
patient-reported
outcomes
(PROs).
Outcomes,
including
PROs
systemic
symptoms,
were
longitudinally
evaluated
registry
participants
receiving
usual
care.
A
total
121
100
CC
studied.
Baseline
cough-specific
PRO
scores
did
not
significantly
differ
between
groups.
There
no
significant
differences
chest
imaging
abnormality
lung
function
However,
proportions
fractional
exhaled
nitric
oxide
(FeNO)
≥
25
ppb
44.7%
those
22.7%
CC,
which
different.
In
longitudinal
assessment
(n
43),
PROs,
such
as
severity
Leicester
Questionnaire
(LCQ)
scores,
improved
visits
1
2
(visit
interval:
median
35
[interquartile
range,
IQR:
23-58]
days).
LCQ
score,
83.3%
showed
improvement
(change
+1.3),
7.1%
had
worsened
(≤
-1.3).
The
number
4
(IQR:
2-7)
at
visit
decreased
0-4)
2.
summary,
similar
overall
CC.
Current
guideline-based
approaches
be
effective
cough.
Measurement
FeNO
levels
also
useful
management.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(2), P. e24053 - e24053
Published: Jan. 1, 2024
After
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
a
series
of
symptoms
may
persist
for
long
time,
which
is
now
called
COVID.
It
was
found
that
COVID
can
affect
all
patients
with
COVID-19.
Therefore,
has
become
hot
topic.
In
this
study,
we
used
the
WOS
database
as
sample
data
source
to
conduct
bibliometric
and
visual
analysis
1765
articles
over
past
three
years
through
VOSviewer
R
package.
The
results
show
countries/authors
in
Europe
United
States
America
contribute
most
articles,
their
cooperation
also
active.
Keyword
co-occurrence
identified
four
clusters,
important
topics
including
mechanism,
clinical
symptoms,
epidemiological
characteristics,
management/treatment
Themes
such
"cognitive
impairment",
"endothelial
dysfunction",
"diagnosis",
"biomarkers"
are
likely
be
focus
new
attention
coming
period.
addition,
put
forward
possible
research
opportunities
on
researchers
practitioners
facilitate
future
research.